Regenxbio Signs Royalty Deal Worth Up to $250 Million With Healthcare Royalty
In This Article:
Regenxbio (RGNX) said Monday it closed a non-dilutive, limited recourse royalty bond agreement of up
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.